{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:40:45Z","timestamp":1792726845136,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":27,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Heart Journal"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ihj.2026.07.010","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T23:56:58Z","timestamp":1785283018000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Amiodarone-Associated Thyroid Dysfunction: Current Evidence and a Practical Approach to Management"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-7280-5479","authenticated-orcid":false,"given":"Sharath","family":"Nagesh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swathi","family":"Maiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9241-4588","authenticated-orcid":false,"given":"Ramya Das Nageri","family":"Kunnath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ihj.2026.07.010_bib1","first-page":"240","article-title":"The effects of amiodarone on the thyroid","volume":"22","author":"Martino","year":"2001","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.ihj.2026.07.010_bib2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nrendo.2009.225","article-title":"Effects of amiodarone therapy on thyroid function","volume":"6","author":"Cohen-Lehman","year":"2010","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"10.1016\/j.ihj.2026.07.010_bib3","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0002-9343(91)90187-3","article-title":"Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism","volume":"91","author":"Trip","year":"1991","journal-title":"Am J Med"},{"key":"10.1016\/j.ihj.2026.07.010_bib4","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1172\/JCI104807","article-title":"Changes in thyroidal function during adaptation to large doses of iodide","volume":"42","author":"Braverman","year":"1963","journal-title":"J Clin Investig"},{"issue":"2","key":"10.1016\/j.ihj.2026.07.010_bib5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000486957","article-title":"2018 European Thyroid Association (ETA) Guidelines for the management of amiodarone-associated thyroid dysfunction","volume":"7","author":"Bartalena","year":"2018","journal-title":"Eur Thyroid J"},{"issue":"6","key":"10.1016\/j.ihj.2026.07.010_bib6","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0033-0620(89)90017-0","article-title":"Amiodarone and thyroid function","volume":"31","author":"Nademanee","year":"1989","journal-title":"Prog Cardiovasc Dis"},{"issue":"3","key":"10.1016\/j.ihj.2026.07.010_bib7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2265.1987.tb00781.x","article-title":"Amiodarone iodine-induced hypothyroidism: risk factors and follow-up in 28 cases","volume":"26","author":"Martino","year":"1987","journal-title":"Clin Endocrinol"},{"issue":"4","key":"10.1016\/j.ihj.2026.07.010_bib8","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1089\/thy.1997.7.541","article-title":"Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis","volume":"7","author":"Bogazzi","year":"1997","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.ihj.2026.07.010_bib9","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1530\/EJE-14-0267","article-title":"The onset time of amiodarone-induced thyrotoxicosis (AIT) depends on AIT type","volume":"171","author":"Tomisti","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.ihj.2026.07.010_bib10","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s40618-023-02168-3","article-title":"Novel concepts in the approach to patients with amiodarone-induced thyrotoxicosis","volume":"47","author":"Cappellani","year":"2024","journal-title":"J Endocrinol Investig"},{"issue":"1","key":"10.1016\/j.ihj.2026.07.010_bib11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jacc.2023.08.017","article-title":"2023 ACC\/AHA\/ACCP\/HRS Guideline for diagnosis and management of atrial fibrillation","volume":"83","author":"Joglar","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"40","key":"10.1016\/j.ihj.2026.07.010_bib12","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.ihj.2026.07.010_bib13","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.ihj.2026.07.010_bib14","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association Guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid"},{"issue":"2","key":"10.1016\/j.ihj.2026.07.010_bib15","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1210\/jc.2011-2390","article-title":"Treatment of amiodarone-induced thyrotoxicosis type 2: a randomized clinical trial","volume":"97","author":"Eskes","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.ihj.2026.07.010_bib16","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1210\/jc.2009-0940","article-title":"Glucocorticoids are preferable to thionamides as first-line treatment for amiodarone-induced thyrotoxicosis due to destructive thyroiditis: a matched retrospective cohort study","volume":"94","author":"Bogazzi","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ihj.2026.07.010_bib17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1210\/jc.2008-1907","article-title":"Amiodarone-induced thyrotoxicosis is a predictor of adverse cardiovascular outcome","volume":"94","author":"Yiu","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ihj.2026.07.010_bib18","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.amjcard.2008.10.019","article-title":"Comparison of atrial fibrillation recurrence rates after successful electrical cardioversion in patients with hyperthyroidism-induced versus non-hyperthyroidism-induced persistent atrial fibrillation","volume":"103","author":"Siu","year":"2009","journal-title":"Am J Cardiol"},{"issue":"24","key":"10.1016\/j.ihj.2026.07.010_bib19","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1056\/NEJMoa1109867","article-title":"Dronedarone in high-risk permanent atrial fibrillation","volume":"365","author":"Connolly","year":"2011","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.ihj.2026.07.010_bib20","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1056\/NEJMoa0800456","article-title":"Increased mortality after dronedarone therapy for severe heart failure","volume":"358","author":"Kober","year":"2008","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ihj.2026.07.010_bib21","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/joim.20115","article-title":"Amiodarone induced thyroid dysfunction: a high cumulative incidence in a nationwide cohort study in Iceland","volume":"298","author":"Gu\u00f0j\u00f3nsson","year":"2025","journal-title":"J Intern Med"},{"issue":"6","key":"10.1016\/j.ihj.2026.07.010_bib22","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1210\/clinem\/dgac756","article-title":"Real-life data on the effect of medical therapy for amiodarone-induced thyrotoxicosis on cardiovascular events and hospitalizations","volume":"108","author":"Cappellani","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ihj.2026.07.010_bib23","doi-asserted-by":"crossref","DOI":"10.1111\/joim.70116","article-title":"Amiodarone-related thyroid dysfunction and associated outcomes in patients with heart failure: a nationwide cohort study","author":"Kristensen","year":"2026","journal-title":"J Intern Med"},{"issue":"11","key":"10.1016\/j.ihj.2026.07.010_bib24","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1210\/jc.2011-1678","article-title":"Continuation of amiodarone delays restoration of euthyroidism in patients with type 2 amiodarone-induced thyrotoxicosis treated with prednisone: a pilot study","volume":"96","author":"Bogazzi","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.ihj.2026.07.010_bib25","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1210\/jc.2012-1797","article-title":"Total thyroidectomy in patients with amiodarone-induced thyrotoxicosis and severe left ventricular systolic dysfunction","volume":"97","author":"Tomisti","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ihj.2026.07.010_bib26","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jca.21705","article-title":"Guidelines on the use of therapeutic apheresis in clinical Practice\u2014Evidence-Based approach from the writing Committee of the American society for apheresis: the eighth special issue","volume":"34","author":"Padmanabhan","year":"2019","journal-title":"J Clin Apher"},{"issue":"4","key":"10.1016\/j.ihj.2026.07.010_bib27","first-page":"54","article-title":"Iodine status in India: a revisit","volume":"67","author":"Joshi","year":"2019","journal-title":"J Assoc Phys India"}],"container-title":["Indian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483226001410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483226001410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:26:49Z","timestamp":1792726009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019483226001410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":27,"alternative-id":["S0019483226001410"],"URL":"https:\/\/doi.org\/10.1016\/j.ihj.2026.07.010","relation":{},"ISSN":["0019-4832"],"issn-type":[{"value":"0019-4832","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amiodarone-Associated Thyroid Dysfunction: Current Evidence and a Practical Approach to Management","name":"articletitle","label":"Article Title"},{"value":"Indian Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ihj.2026.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Cardiological Society of India. Published by Elsevier, a division of RELX India, Pvt. Ltd.","name":"copyright","label":"Copyright"}]}}